Tango Therapeutics Inc (NAS:TNGX)
$ 9.982 0.31 (3.2%) Market Cap: 1.07 Bil Enterprise Value: 752.88 Mil PE Ratio: 0 PB Ratio: 4.18 GF Score: 52/100

Tango Therapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript

Feb 16, 2023 / 02:20PM GMT
Release Date Price: $5.36 (-5.63%)
Andy Berens
SVB Securities - Analyst

Good morning, everyone. I'm Andy Berens, Senior Biotech Analyst and Head of Targeted Oncology for SVB Securities. Thanks for joining us on the final day of our 12th Annual Global Healthcare Conference. We are very excited this morning to have with us from Tango Therapeutics, Barbara Weber, President and CEO of the company.

Barbara, thank you for joining us in this session and walking us through your company.

Barbara Weber
Tango Therapeutics, Inc. - President & CEO

Thanks for the invitation.

Andy Berens
SVB Securities - Analyst

Sure. And just as a reminder to investors, you can ask questions by typing it in to the bar directly below the window. I have some questions in the meantime, but if you have any questions, please ask them, and we will leave them in.

Questions & Answers

Andy Berens
SVB Securities - Analyst

Barbara, for those that may not be familiar with Tango, can you give a brief overview of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot